An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein toxic oligomers

We describe the integration of the peptide in a lab-on-a-chip plasmonic platform suitable for point-of-care measurements of αS toxic oligomers in CSF samples in real-time and at an affordable cost, providing an innovative biosensor for PD early diagnosis in the clinic.PMID:38637056 | DOI:10.1016/j.aca.2024.342559
Source: Analytica Chimica Acta - Category: Chemistry Authors: Source Type: research